| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 7.5/gram
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Entresto is a combination of sacubitril, an enkephalinase inhibitor, and valsartan, an angiotensin II receptor blocker to reduce the risk of cardiovascular death in patients with heart failure and hospitalization for chronic heart failure (NYHAII-IV) And the ejection fraction is reduced.
Entresto is usually administered in combination with other heart failure, in the place of ACE inhibitors or ARBs.
| ATP | AMP-NA2 | ADP-NA2 | CMP |
| CMP-NA2 | CDP | GMP | UMP |
| UDP | UTP | IDP | DB-CAMP |
){kind=link}